<DOC>
	<DOCNO>NCT01403597</DOCNO>
	<brief_summary>The study design determine safety , efficacy , patient comfort patient satisfaction combine treatment Refirme ST Matrix RF device approve 510k clearance . The evaluation include skin condition , physician/subject improvement assessment , subject comfort satisfaction score questionnaire .</brief_summary>
	<brief_title>Evaluation Non-ablative Fractional Combination Treatment Improvement Skin 's Appearance</brief_title>
	<detailed_description>The Refirme ST Matrix RF applicator FDA approve device indicate improvement skin appearance . The Matrix RF applicator FDA clearance ablation , resurface skin , wrinkle treatment , whereas Refirme-ST applicator FDA clearance non-invasive wrinkle treatment . The combined treatment Refirme ST Matrix RF intend improve skin appearance enhancement collagen production result Refirme ST primary heating treat area cause ablation resurface skin Matrix RF . In current clinical setting , applicator use separate session although contra-indication preventing usage applicator treatment session . A combined treatment one session believe efficient time effective patient therefore commercial benefit manufacturer .</detailed_description>
	<criteria>Have skin condition require ablation resurface visible line , pore , pigmentation , elastosis correlate score 2 6 Fitzpatrick Classification Wrinkling Degree Elastosis Age : At least 21 year age old 65 year age Sex male female For female candidate postmenopausal surgically sterilize , use medically acceptable form birth control least 3 month prior enrollment entire course study ( i.e. , oral contraceptive , IUD , contraceptive implant , barrier method spermicide , abstinence ) . Agrees sign Informed Consent Desire improve facial skin appearance Willingness photograph treat area take may use marketing educational presentation and/or publication Willingness follow treatment followup schedule posttreatment care Not plan improve skin appearance different procedure complete experimental period . History keloid scar abnormal wound heal Suffering current history significant skin condition treat area inflammatory skin condition , include , limited : excessive skin dryness , psoriasis , eczema , rash , rosacea ( particularly severe open wound stage ) , indurate acne , varicella scar , open laceration abrasion active cold sore herpes sore prior treatment ( duration resolution per Investigator 's discretion ) treatment course . History epidermal dermal disorder ( particularly involve collagen microvascularity ) . History pigmentary disorder , particularly tendency hyper hypopigmentation Vascular lesion , tattoo permanent makeup treat area Excessively tan area treat unable/unlikely refrain tan study . Pregnant plan become pregnant , give birth le 3 month ago , and/or breastfeed . Suffering hormonal imbalance , per Investigator 's discretion . Having active electrical implant anywhere body , pacemaker internal defibrillator Having permanent implant treat area , metal plate screw , injected chemical substance . Having history disease stimulate heat , recurrent Herpes Simplex treat area , unless treatment conduct follow prophylactic regimen . History immunosuppression/immune deficiency disorder ( include HIV infection AIDS ) currently use immunosuppressive medication . Having undergoing form treatment active cancer , history skin cancer cancer area treat , include presence malignant premalignant pigment lesion . Suffering significant concurrent illness , cardiac disorder , diabetes ( type I II ) , pertinent neurological disorder . As per Investigator 's discretion , physical mental condition might make unsafe subject participate study . Use isotretinoin ( AccutaneÂ® ) within 6 month treatment study Use nonsteroidal antiinflammatory drug ( NSAIDS , e.g. , ibuprofencontaining agent ) one week treatment session Use retinoids , antioxidant skin nourish supplement within 2 month treatment study . Having undergone surgery treat area within 6 month treatment ( skin heal completely ) study Having know anticoagulative thromboembolic condition take anticoagulation medication one week prior treatment course ( allow inclusion , temporary cessation use per subject 's physician discretion ) . Having receive treatment lightbased , radiofrequency device within 3 month prior treatment study . Having receive facial dermabrasion chemical peel treatment within 3 month treatment study . Having receive Botox/collagen/fat injection method augmentation inject implanted material treat area within 3 month treatment study Having undergone resurfacing procedure , face lift eyelid surgery within year treatment study Participation study another device drug within one month prior enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Skin wrinkling</keyword>
	<keyword>Skin age</keyword>
	<keyword>Skin pigmentation</keyword>
</DOC>